Director of Stoke Therapeutics, Inc. (NASDAQ:STOK), Tzianabos Arthur, sells 10,000 shares worth $606,652
According to Stoke Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Feb 23 05:28 PM, company Director, Tzianabos Arthur disclosed selling 10,000 shares at a cost of $60.67. At the time of this transaction (Feb 19), this trade was worth $606,652 in total. As of Feb 19, Tzianabos Arthur now owns 0 shares in total worth about $0.0.
For the last few recent trades made by Stoke Therapeutics, Inc. (NASDAQ:STOK) Director, Tzianabos Arthur, we have the following information:
- SEC Form 4 filing: Nov 23: Sold 20,000 shares at the rate of $46.03 per share. Total worth of this trade was $920,566. Total number of shares owned as of Nov 23 were 0
Posted by
George Daniels
on Tuesday February 23 2021, 8:00 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
